Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants

Simple item page
dc.contributor.authorHesseling A.C.
dc.contributor.authorCotton M.F.
dc.contributor.authorFordham Von Reyn C.
dc.contributor.authorGraham S.M.
dc.contributor.authorGie R.P.
dc.contributor.authorHussey G.D.
dc.date.accessioned2011-05-15T15:53:48Z
dc.date.available2011-05-15T15:53:48Z
dc.date.issued2008
dc.description.abstractThis document outlines the consensus agreement from the Union's BCG Working Group regarding BCG vaccination in HIV-infected infants, in response to recently revised World Health Organization (WHO) guidelines, which make HIV infection in infants a full contraindication to bacille Calmette-Guérin (BCG) vaccination. BCG is one of the most widely given vaccines globally and is safe in immunocompetent individuals. Recent evidence shows that HIV-infected infants who were routinely vaccinated with BCG at birth, when asymptomatic, and who later developed AIDS, are at high risk of developing disseminated BCG disease (estimated incidence 407-1300 per 100000). The document outlines requirements to implement selective BCG vaccination strategies in infants born to HIV-infected women and strategies to reduce the risk of vertical HIV transmission and disseminated BCG disease in infants. © 2008 The Union.
dc.description.versionReview
dc.identifier.citationInternational Journal of Tuberculosis and Lung Disease
dc.identifier.citation12
dc.identifier.citation12
dc.identifier.issn10273719
dc.identifier.urihttp://hdl.handle.net/10019.1/8816
dc.titleConsensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants
dc.typeReview
Files
Collections
Stellenbosch University - Scopus Publications